Total Payments
$27,856
2024 Payments
$1,212
Companies
59
Transactions
584
Medicare Patients
4,636
Medicare Billing
$891,903
Payment Breakdown by Category
Food & Beverage$11,833 (42.5%)
Travel$7,686 (27.6%)
Other$6,275 (22.5%)
Research$1,041 (3.7%)
Education$1,021 (3.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,833 | 528 | 42.5% |
| Travel and Lodging | $7,686 | 23 | 27.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,275 | 3 | 22.5% |
| Unspecified | $1,041 | 1 | 3.7% |
| Education | $1,021 | 29 | 3.7% |
Payments by Type
General
$26,815
583 transactions
Research
$1,041
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AMAG Pharmaceuticals, Inc. | $8,160 | 32 | $0 (2019) |
| Medical Device Business Services, Inc. | $3,216 | 23 | $0 (2023) |
| Axonics, Inc. | $1,396 | 25 | $0 (2023) |
| Boston Scientific Corporation | $1,335 | 8 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,239 | 73 | $0 (2024) |
| BIOTISSUE HOLDINGS INC. | $1,181 | 12 | $0 (2024) |
| Valencia Technologies Corporation | $1,119 | 3 | $0 (2023) |
| Covidien LP | $1,074 | 3 | $0 (2017) |
| PFIZER INC. | $857.17 | 62 | $0 (2024) |
| DENTSPLY IH Inc. | $823.64 | 76 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,212 | 50 | DENTSPLY IH AB ($288.59) |
| 2023 | $4,214 | 84 | Medical Device Business Services, Inc. ($1,487) |
| 2022 | $3,368 | 73 | BioTissue Holdings, Inc. ($1,134) |
| 2021 | $2,163 | 81 | Acessa Health Inc. ($771.80) |
| 2020 | $2,042 | 60 | Boston Scientific Corporation ($1,272) |
| 2019 | $1,460 | 94 | DENTSPLY IH Inc. ($267.17) |
| 2018 | $8,970 | 60 | AMAG Pharmaceuticals, Inc. ($8,047) |
| 2017 | $4,427 | 82 | Medical Device Business Services, Inc. ($1,729) |
All Payment Transactions
584 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: UROLOGY | ||||||
| 11/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 11/22/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Hematology | ||||||
| 10/31/2024 | Boston Scientific Corporation | Advantage System (Device) | Food and Beverage | In-kind items and services | $38.26 | General |
| Category: Advantage_URO | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Gastroenterology | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $103.68 | General |
| Category: Obesity | ||||||
| 09/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.46 | General |
| Category: Gastroenterology | ||||||
| 09/17/2024 | CooperSurgical, Inc. | Endosee (Device) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Gastroenterology | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: Gastroenterology | ||||||
| 08/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Gastroenterology | ||||||
| 08/14/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $22.05 | General |
| 08/05/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $14.26 | General |
| 07/30/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Oncology | ||||||
| 07/25/2024 | Exeltis, USA Inc. | NUVESSA (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: ANTIBIOTIC | ||||||
| 07/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Gastroenterology | ||||||
| 07/15/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Medical Urology | ||||||
| 07/11/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Hematology | ||||||
| 07/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: Gastroenterology | ||||||
| 06/20/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $30.42 | General |
| Category: Medical Urology | ||||||
| 05/28/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/27/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Medical Urology | ||||||
| 05/21/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Iron Deficiency Anemia | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Usability Study | Covidien LP | $1,041 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,205 | 2,268 | $950,119 | $241,771 |
| 2022 | 19 | 1,173 | 2,117 | $874,845 | $227,631 |
| 2021 | 20 | 1,345 | 2,598 | $1.0M | $273,029 |
| 2020 | 17 | 913 | 1,994 | $688,058 | $149,472 |
Total Patients
4,636
Total Services
8,977
Medicare Billing
$891,903
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 203 | 704 | $267,520 | $70,828 | 26.5% |
| 58558 | Biopsy of lining of uterus and/or removal of polyp using an endoscope | Office | 2023 | 41 | 42 | $168,000 | $48,662 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 134 | 333 | $116,550 | $23,041 | 19.8% |
| 58267 | Removal of uterus with repair for incontinence, 250.0 g or less | Facility | 2023 | 23 | 23 | $69,000 | $20,405 | 29.6% |
| 51729 | Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | Office | 2023 | 53 | 55 | $52,250 | $17,763 | 34.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $31,500 | $9,329 | 29.6% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 53 | 55 | $27,675 | $9,095 | 32.9% |
| 57160 | Fitting and insertion of vaginal support device | Office | 2023 | 73 | 142 | $28,400 | $8,398 | 29.6% |
| 57283 | Repair of prolapsing vaginal vault through vagina | Facility | 2023 | 23 | 23 | $57,500 | $6,682 | 11.6% |
| 57061 | Simple destruction of growth of vagina | Office | 2023 | 23 | 47 | $23,500 | $6,598 | 28.1% |
| A4562 | Pessary, non rubber, any type | Office | 2023 | 56 | 97 | $19,400 | $5,006 | 25.8% |
| 56501 | Simple destruction of growth of external female genitals | Office | 2023 | 11 | 23 | $17,037 | $3,499 | 20.5% |
| 57150 | Irrigation of vagina and/or application of drug to treat infection | Office | 2023 | 75 | 140 | $30,568 | $3,411 | 11.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 16 | $7,200 | $2,116 | 29.4% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 41 | 41 | $2,665 | $1,880 | 70.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 45 | 45 | $2,925 | $1,846 | 63.1% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 53 | 56 | $17,275 | $1,533 | 8.9% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 127 | 265 | $6,625 | $1,044 | 15.8% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 55 | 57 | $3,679 | $346.86 | 9.4% |
| 81025 | Urine pregnancy test | Office | 2023 | 32 | 34 | $850.00 | $286.96 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 220 | 707 | $268,660 | $70,163 | 26.1% |
| 58558 | Biopsy of lining of uterus and/or removal of polyp using an endoscope | Office | 2022 | 41 | 46 | $184,000 | $53,564 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 123 | 288 | $100,800 | $20,678 | 20.5% |
| 51729 | Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | Office | 2022 | 59 | 59 | $56,050 | $19,705 | 35.2% |
| 58267 | Removal of uterus with repair for incontinence, 250.0 g or less | Facility | 2022 | 16 | 16 | $48,000 | $14,206 | 29.6% |
About Dr. Vikas Merchia, M.D
Dr. Vikas Merchia, M.D is a Obstetrics healthcare provider based in Brockton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811966948.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vikas Merchia, M.D has received a total of $27,856 in payments from pharmaceutical and medical device companies, with $1,212 received in 2024. These payments were reported across 584 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($11,833).
As a Medicare-enrolled provider, Merchia has provided services to 4,636 Medicare beneficiaries, totaling 8,977 services with total Medicare billing of $891,903. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics
- Other Specialties Urogynecology and Reconstructive Pelvic Surgery, Obstetrics & Gynecology
- Location Brockton, MA
- Active Since 03/14/2006
- Last Updated 04/24/2024
- Taxonomy Code 207VX0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811966948
Products in Payments
- INTRAROSA (Drug) $8,160
- HARMONIC Product Family (Device) $1,810
- SOLYX (Device) $1,272
- eCoin Device Kit (Device) $1,119
- LoFric (Device) $1,005
- ACESSA PROVU SYSTEM (Device) $791.96
- TRULANCE (Drug) $783.58
- Axonics (Device) $728.78
- PREMARIN (Drug) $608.20
- MYFEMBREE (Drug) $554.11
- Bulkamid (Device) $498.12
- INTERSTIM (Device) $469.77
- XIFAXAN (Drug) $455.19
- LOFRIC (Device) $288.59
- ALTIS (Device) $275.63
- DERMABOND Portfolio (Device) $254.44
- IMVEXXY (Drug) $229.80
- IBSRELA (Drug) $223.99
- Axonics r-SNM System (Device) $215.17
- Wegovy (Drug) $190.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.